Publication:
Predictive value of control of COPD for risk of exacerbations: An international, prospective study.

dc.contributor.authorMiravitlles, Marc
dc.contributor.authorSliwinski, Pawel
dc.contributor.authorRhee, Chin Kook
dc.contributor.authorCostello, Richard W
dc.contributor.authorCarter, Victoria
dc.contributor.authorTan, Jessica H Y
dc.contributor.authorLapperre, Therese S
dc.contributor.authorAlcazar, Bernardino
dc.contributor.authorGouder, Caroline
dc.contributor.authorEsquinas, Cristina
dc.contributor.authorGarcía-Rivero, Juan Luis
dc.contributor.authorKemppinen, Anu
dc.contributor.authorTee, Augustine
dc.contributor.authorRoman-Rodríguez, Miguel
dc.contributor.authorSoler-Cataluña, Juan José
dc.contributor.authorPrice, David B
dc.contributor.authorRespiratory Effectiveness Group (REG)
dc.date.accessioned2023-02-08T14:44:49Z
dc.date.available2023-02-08T14:44:49Z
dc.date.issued2020-04-06
dc.description.abstractThe concept of clinical control in COPD has been developed to help in treatment decisions, but it requires validation in prospective studies. This international, multicentre, prospective study aimed to validate the concept of control in COPD. Patients with COPD were classified as controlled/uncontrolled by clinical criteria or CAT scores at baseline and followed up for 18 months. The main outcome was the difference in rate of a composite endpoint of moderate and severe exacerbations or death over the 18-month follow-up period. A total of 307 patients were analysed (mean age = 68.6 years and mean FEV1 % = 52.5%). Up to 65% and 37.9% of patients were classified as controlled by clinical criteria or CAT, respectively. Controlled patients had significantly less exacerbations during follow-up (by clinical criteria: 1.1 vs 2.6, P Control status, defined by easy-to-obtain clinical criteria, is predictive of future exacerbation risk and time to the next exacerbation. The concept of control can be used in clinical practice at each clinical visit as a complement to the current recommendations of initial treatment proposed by guidelines.
dc.identifier.doi10.1111/resp.13811
dc.identifier.essn1440-1843
dc.identifier.pmid32249487
dc.identifier.unpaywallURLhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/resp.13811
dc.identifier.urihttp://hdl.handle.net/10668/15324
dc.issue.number11
dc.journal.titleRespirology (Carlton, Vic.)
dc.journal.titleabbreviationRespirology
dc.language.isoen
dc.organizationAPES Hospital de Poniente de Almería
dc.page.number1136-1143
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectChronic Obstructive Pulmonary Disease Assessment Test
dc.subjectclinical control status
dc.subjectdyspnoea
dc.subjectexacerbations
dc.subjectprevention
dc.subject.meshAged
dc.subject.meshClinical Decision Rules
dc.subject.meshDisease Progression
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInternational Cooperation
dc.subject.meshMale
dc.subject.meshPatient Selection
dc.subject.meshPractice Patterns, Physicians'
dc.subject.meshPredictive Value of Tests
dc.subject.meshProspective Studies
dc.subject.meshPulmonary Disease, Chronic Obstructive
dc.subject.meshSymptom Flare Up
dc.titlePredictive value of control of COPD for risk of exacerbations: An international, prospective study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number25
dspace.entity.typePublication

Files